Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Change in Receivables (2016 - 2024)

Prothena Corp Public has reported Change in Receivables over the past 11 years, most recently at -$5.2 million for Q1 2024.

  • Quarterly results put Change in Receivables at -$5.2 million for Q1 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was -$5.2 million (down 200.0% YoY), and the annual figure for FY2024 was -$5.2 million, down 200.0%.
  • Change in Receivables for Q1 2024 was -$5.2 million at Prothena Corp Public, down from $4.6 million in the prior quarter.
  • Over the last five years, Change in Receivables for PRTA hit a ceiling of $4.6 million in Q3 2023 and a floor of -$5.2 million in Q1 2024.
  • Median Change in Receivables over the past 4 years was -$7000.0 (2020), compared with a mean of -$6181.8.
  • Peak annual rise in Change in Receivables hit 2020.0% in 2020, while the deepest fall reached 1585.71% in 2020.
  • Prothena Corp Public's Change in Receivables stood at -$7000.0 in 2020, then plummeted by 1028.57% to -$79000.0 in 2021, then skyrocketed by 5967.09% to $4.6 million in 2023, then plummeted by 211.31% to -$5.2 million in 2024.
  • The last three reported values for Change in Receivables were -$5.2 million (Q1 2024), $4.6 million (Q3 2023), and $524000.0 (Q2 2023) per Business Quant data.